Home
|
Help
|
Contact
Sign in
WPRIM Management System>
DCMS
>
Clinical and Molecular Hepatology
>
2015
>
21
>
3
Volume:
21
Issue:
3
1. Portal flow steal after liver transplantation.
Page:314—317
2. Sarcomatoid cholangiocarcinoma with osteoclast-like giant cells associated with hepatolithiasis: A case report.
Page:309—313
3. A case of hepatoblastoma misdiagnosed as combined hepatocellular carcinoma and cholangiocarcinoma in an adult.
Page:300—308
4. Imaging findings for intravascular large B-cell lymphoma of the liver.
Page:295—299
5. Long-term outcomes of patients with advanced hepatocellular carcinoma who achieved complete remission after sorafenib therapy.
Page:287—294
6. Growth rate of early-stage hepatocellular carcinoma in patients with chronic liver disease.
Page:279—286
7. Preference elicitation approach for measuring the willingness to pay for liver cancer treatment in Korea.
Page:268—278
8. Influence of P53 on the radiotherapy response of hepatocellular carcinoma.
Page:257—267
9. Comparison and analysis of the prevalence of hepatitis C virus infection by region in the Republic of Korea during 2005-2012.
Page:249—256
10. Entecavir plus tenofovir versus entecavir plus adefovir in chronic hepatitis B patients with a suboptimal response to lamivudine and adefovir combination therapy.
Page:242—248
11. Static and dynamic prognostic factors for hepatitis-B-related acute-on-chronic liver failure.
Page:232—241
12. P53 expression in hepatocellular carcinoma: influence on the radiotherapeutic response of the hepatocellular carcinoma.
Page:230—231
13. The mutational landscape of hepatocellular carcinoma.
Page:220—229
14. Managing alcoholic liver disease.
Page:212—219
15. Personalized management of cirrhosis by non-invasive tests of liver fibrosis.
Page:200—211
16. From DCPD to NTCP: The long journey towards identifying a functional hepatitis B virus receptor.
Page:193—199